Dividends
Dividend payments are $0.87 per share, with a current dividend yield of 0.25%. The company has dividend history for 33 consecutive years.
WST Dividend Summary
0.25%
$0.87
11.61%
13.89%
Consecutive Years
33
Most Recent Ex-Date
Apr 29, 2026
Most Recent Payment
May 6, 2026
WST Dividends per Share (Nominal History)
View full nominal table listThis step chart displays the nominal dividend payouts over time on their actual payment dates, matching the distribution frequency.
WST Dividends CAGR Chart
West Pharmaceutical Services, Inc. (WST)
Annual Dividend History
| Year | Dividend/Share | YoY Growth |
|---|---|---|
| 2026(YTD) | $0.44 | — |
| 2025 | $0.85 | +4.94% |
| 2024 | $0.81 | +5.19% |
| 2023 | $0.77 | +5.48% |
| 2022 | $0.73 | +5.80% |
| 2021 | $0.69 | +6.15% |
| 2020 | $0.65 | +6.56% |
| 2019 | $0.61 | +7.02% |
| 2018 | $0.57 | +7.55% |
| 2017 | $0.53 | +8.16% |
| 2016 | $0.49 | +8.89% |
| 2015 | $0.45 | +9.76% |
| 2014 | $0.41 | +6.49% |
| 2013 | $0.39 | +5.48% |
| 2012 | $0.36 | +5.80% |
| 2011 | $0.34 | +6.15% |
| 2010 | $0.33 | +6.56% |
| 2009 | $0.30 | +7.02% |
| 2008 | $0.29 | +7.55% |
| 2007 | $0.27 | +8.16% |
Quarterly Dividend History
| Quarter | Dividend/Share | YoY Growth |
|---|---|---|
| Q2 2026 | $0.22 | +4.76% |
| Q1 2026 | $0.22 | +4.76% |
| Q4 2025 | $0.22 | +4.76% |
| Q3 2025 | $0.21 | +5.00% |
| Q2 2025 | $0.21 | +5.00% |
| Q1 2025 | $0.21 | +5.00% |
| Q4 2024 | $0.21 | +5.00% |
| Q3 2024 | $0.20 | +5.26% |
| Q2 2024 | $0.20 | +5.26% |
| Q1 2024 | $0.20 | +5.26% |
| Q4 2023 | $0.20 | +5.26% |
| Q3 2023 | $0.19 | +5.56% |
| Q2 2023 | $0.19 | +5.56% |
| Q1 2023 | $0.19 | +5.56% |
| Q4 2022 | $0.19 | +5.56% |
| Q3 2022 | $0.18 | +5.88% |
| Q2 2022 | $0.18 | +5.88% |
| Q1 2022 | $0.18 | +5.88% |
| Q4 2021 | $0.18 | +5.88% |
| Q3 2021 | $0.17 | +6.25% |
| Q2 2021 | $0.17 | +6.25% |
| Q1 2021 | $0.17 | +6.25% |
| Q4 2020 | $0.17 | +6.25% |
| Q3 2020 | $0.16 | +6.67% |
Dividend Yield Metrics
- Current Yield
- 0.25%
- Average Yield (TTM)
- 0.25%
- Average Yield (3Y)
- 0.23%
- Forward Yield on Cost (3Y)
- 0.31%
- Forward Yield on Cost (5Y)
- 0.36%
- Forward Yield on Cost (10Y)
- 0.50%
Payout Ratio Analysis
- Payout Ratio (Current)
- 11.61%
- FCF Payout Ratio
- 13.89%
- Payout Ratio (3Y Avg)
- 11.36%
- Payout Ratio (5Y Avg)
- 10.22%
- FCF Payout (3Y Avg)
- 16.10%
- FCF Payout (5Y Avg)
- 15.24%
Dividend Coverage
About West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Eric Green